PROT — Stromacel Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2007 December 31st | 2008 December 31st | C2009 December 31st | C2010 December 31st | 2011 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PRESS | 10-K | 10-K | 10-K/A | 10-K/A |
Standards: | — | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.026 | 0.132 | 0.142 | 0.083 | 0.026 |
Cost of Revenue | |||||
Gross Profit | 0.016 | 0.114 | 0.118 | 0.067 | 0.027 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 2.17 | 4.99 | 3.96 | 3.53 | 1.33 |
Operating Profit | -2.15 | -4.86 | -3.82 | -3.45 | -1.31 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.17 | -4.97 | -3.86 | -3.47 | -1.38 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.17 | -4.97 | -3.86 | -3.47 | -1.38 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.17 | -4.97 | -3.86 | -3.47 | -1.38 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -2.17 | -4.97 | -3.86 | -3.47 | -1.38 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.684 | -2.33 | -1.16 | -0.749 | -0.211 |
Dividends per Share |